chenodeoxycholic acid has been researched along with Hypertrophy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burgermeister, E; Ebeling, M; Ebert, MP; Einwächter, H; Fan, L; Geisler, F; Hiber, M; Rauser, S; Röcken, C; Schmid, RM; Walch, A; Wright, MB; Xing, X | 1 |
1 other study(ies) available for chenodeoxycholic acid and Hypertrophy
Article | Year |
---|---|
Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy.
Topics: Animals; Cell Line; Cell Line, Tumor; Chenodeoxycholic Acid; Disease Models, Animal; DNA-Binding Proteins; Female; Hepatocytes; Hepatomegaly; Homeodomain Proteins; Humans; Hypertrophy; Introns; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2009 |